Interrupted Time Series Analysis of Vancomycin Compared to Cefuroxime for Surgical Prophylaxis in Patients Undergoing Cardiac Surgery
Authors:
- 1 February 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (2) , 446-451
Abstract
The increased incidence of methicillin-resistant Staphylococcus aureus (MRSA), the emergence of community-acquired MRSA, and the continued high incidence of methicillin-resistant Staphylococcus epidermidis have required that certain institutions choose vancomycin for surgical prophylaxis. However, the data supporting the use of vancomycin for surgical prophylaxis are controversial. The purpose of this project was to assess the effect of the change from cefuroxime to vancomycin for surgical site infection (SSI) rates in patients undergoing coronary artery bypass graft (CABG) surgery. The monthly rates of SSIs from 2001 to 2005 were analyzed before and after a change from cefuroxime to vancomycin antibiotic prophylaxis in patients undergoing CABG by using an interrupted time series analysis. Patients who underwent cardiac valve replacement surgery and who had received vancomycin during the entire study period were used as a comparator group. A total of 6,465 patients underwent CABG surgery ( n = 4,239) or valve replacement surgery ( n = 2,226) during the study period. On average, the monthly SSI incidence rate in patients undergoing CABG surgery decreased by 2.1 cases per 100 surgeries after the switch from cefuroxime to vancomycin ( P = 0.042) when patients undergoing valve replacement were used as a comparator group. The change in SSI rates was associated with a decrease in the incidence of infections caused by coagulase-negative Staphylococcus and MRSA isolates, with little change in the incidence of SSIs due to other gram-positive organisms or gram-negative organisms. In institutions with a high incidence of methicillin-resistant Staphylococcus species, this study provides evidence for the clinical efficacy of vancomycin prophylaxis for the prevention of postoperative SSIs in patients undergoing CABG surgery.Keywords
This publication has 27 references indexed in Scilit:
- Methicillin-ResistantS. aureusInfections among Patients in the Emergency DepartmentNew England Journal of Medicine, 2006
- Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infectionsJournal of Antimicrobial Chemotherapy, 2006
- Are Cephalosporins Adequate for Antimicrobial Prophylaxis for Cardiac Surgery Involving Implants?Clinical Infectious Diseases, 2005
- Antimicrobial Prophylaxis for Surgery: An Advisory Statement from the National Surgical Infection Prevention ProjectClinical Infectious Diseases, 2004
- Glycopeptides Are No More Effective than -Lactam Agents for Prevention of Surgical Site Infection after Cardiac Surgery: A Meta-analysisClinical Infectious Diseases, 2004
- Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysisJournal of Antimicrobial Chemotherapy, 2003
- Segmented regression analysis of interrupted time series studies in medication use researchJournal of Clinical Pharmacy and Therapeutics, 2002
- Clinical, Microbiological, and Economic Benefit of a Change in Antibiotic Prophylaxis for Cardiac SurgeryInfection Control & Hospital Epidemiology, 2002
- On a measure of lack of fit in time series modelsBiometrika, 1978
- Intervention Analysis with Applications to Economic and Environmental ProblemsJournal of the American Statistical Association, 1975